$3.340
-0.068 (-2.05%)收盤時
SSII 資訊
SSII 事件
SS Innovations Appoints Sarah Romano as CFO
SS Innovations (SSII) announced the appointment of Sarah Romano as CFO, effective August 3. Romano will be based in the United States. Most recently, Romano served as CFO of Vicarious Surgical (RBOT).
SS Innovations Surpasses 10,500 Cumulative Surgeries
SS Innovations announced that more than 10,500 cumulative surgeries have been successfully performed with the company's SSi Mantra surgical robotic system. As of April 30, the cumulative number of multi-specialty procedures completed with the SSi Mantra exceeded 10,500, including more than 500 cardiac procedures, 170 telesurgeries, and 125 pediatric surgeries. Additionally, approximately 2,100 physicians have been trained on the SSi Mantra, which has been utilized to perform over 170 different types of procedures.
SS Innovations Files to Sell 5.02M Shares of Common Stock
SS Innovations files to sell 5.02M shares of common stock for holders
SS Innovations Files $150M Mixed Securities Shelf
SS Innovations files $150M mixed securities shelf
SS Innovations Receives Regulatory Approval for SSi Mantra Surgical Robotic System
SS Innovations announced that the company has received regulatory approval for the SSi Mantra surgical robotic system, for multiple indications in Colombia, Oman, Sri Lanka and Kenya. The company received regulatory approval for the SSi Mantra from the Instituto Nacional de Vigilancia de Medicamentos y Alimentos in Colombia in November 2025, from the Directorate General of Pharmaceutical Affairs and Drug Control in Oman in November 2025, from the National Medicines Regulatory Authority in Sri Lanka in January, and from the Pharmacy and Poisons Board in Kenya in January.
本頁僅供研究參考，不構成投資建議。模型可能出錯。過往表現不代表未來結果。